... soon for the 61st Annual Meeting of the Rocky Mou..., being held 11-13 May 2009 in Orem, Utah. Utah V...heir new library building on the UVU campus. Brigh...l program, presented by academic and industry scie...ill highlight cutting-edge scientific research in ...
...ers at the University of Illinois have developed a...delivery of one or more molecules into the cytopla...ferrying tiny amounts of cargo, the nanoneedle can...n optical biosensor., "Nanoneedle-based delivery ...cesses and biophysical properties at the molecular...
...athletic trainers associated with National Collegi... they were following best practice standards for m...a new study. , For athletes with asthma, the dang...thletic performance or so severe to be incapacitat...e American College of Sports Medicine,s journal, ...
Other Biology News:Geoscientists meet to discuss Rocky Mountain geology 2Nanoneedle is small in size, but huge in applications 2Athletes with asthma need more help from their team trainers 2
Cassette, Sal I from Takara Mirus Bio
pZeoSV2(+) Vector Kit from Invitrogen
Rabbit anti-QKI AbVantage Pack Polyclonal Antibody, Unconjugated from Bethyl Laboratories
Acrylamide from GE Healthcare, formerly Amersham Biosciences
Biology Products:(Date:11/24/2009).../PRNewswire/--HealthRoboticstodayannounced,thatith...ed,investors.ThisrecentlyformedToronto-basedcompan...andwillmarket,install,andsupport,HealthRobotics,i....onaryproductofferingsi.v.STATION(TM),i.v.SOFT(TM),...eassistanceonan"asneeded,basis"toitsstrategicpartn...
(Date:11/24/2009)...ire-FirstCall/--CellTherapeutics,Inc.(CTI)(Nasdaqa...erJaffrayHealthCareConference.Theconferencewillbeh... CTIwillpresentonTuesday,December1at11:00a.m.Easte...presentationwillbeavailableat www.celltherapeutics... , ,PiperJaffrayHealthCareConference,NewYorkPalac...
(Date:11/23/2009)...ltra-fast communication, computation and more powe...ying to use quantum states as carriers of informat...sicists have shown, mathematically, how to gently ... while keeping the information intact. Their work ...ew Letters and highlighted with a Viewpoint in P...
(Date:11/23/2009)...PRNewswire-FirstCall/-YMBioSciencesInc.(NYSEAmex: ...ythatidentifiesandadvancesadiverseportfolioofpromi...ment,todayreportedthatCytopia(ASX:CYT)hascommenced...t,orally-administeredJAK1/JAK2inhibitor.Thetrialis...roposaltomergeCytopiaintoYMhasbeenpreviouslyannoun...
Breaking Biology Technology:Health Robotics Continues its Global Expansion With December 09 ASHP's Launch of Joint Venture in Canada 2YM BIOSCIENCES REPORTS FIRST PATIENT IN PHASE I/II TRIAL OF JAK1/JAK2 INHIBITOR, CYT387 ENROLLED BY CYTOPIA 2YM BIOSCIENCES REPORTS FIRST PATIENT IN PHASE I/II TRIAL OF JAK1/JAK2 INHIBITOR, CYT387 ENROLLED BY CYTOPIA 3YM BIOSCIENCES REPORTS FIRST PATIENT IN PHASE I/II TRIAL OF JAK1/JAK2 INHIBITOR, CYT387 ENROLLED BY CYTOPIA 4